Difference between revisions of "ATC code C"
From Self-sufficiency
m (robot Modifying: zh:ATC代码C) |
m |
||
| Line 7: | Line 7: | ||
[[Category:ATC codes|C]] | [[Category:ATC codes|C]] | ||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
Latest revision as of 18:20, 27 September 2011
ATC code C Cardiovascular system is a section of the Anatomical Therapeutic Chemical Classification System, a system of alphanumeric codes developed by the WHO for the classification of drugs and other medical products.[1]
Codes for veterinary use (ATCvet codes) can be created by placing the letter Q in front of the human ATC code: QC...[2]National issues of the ATC classification may include additional codes not present in this list, which follows the WHO version.
| C Cardiovascular system |
|---|
| C01 Cardiac therapy |
| C02 Antihypertensives |
| C03 Diuretics |
| C04 Peripheral vasodilators |
| C05 Vasoprotectives |
| C07 Beta blocking agents |
| C08 Calcium channel blockers |
| C09 Agents acting on the renin-angiotensin system |
| C10 Lipid modifying agents |
|
|
References
Cite error: Invalid <references> tag;
parameter "group" is allowed only.
<references />, or <references group="..." />- ↑ "ATC Index". WHO Collaborating Centre for Drug Statistics Methodology.
- ↑ "ATCvet Index". WHO Collaborating Centre for Drug Statistics Methodology.
